After completing this CME activity, physicians should be able to:

• Describe the phenomenology of drug-induced acute dystonia, akathisia, parkinsonism and tardive dyskinesia.
  

• Give reasons why these extrapyramidal syndromes may go unrecognized in patients receiving antipsychotic medications.
  

• Identify patients at increased risk for these syndromes.

• Describe effects these syndromes can have on daily living and compliance with therapy.
  

• Explain prevention and treatment or management methods for each syndrome.
  

• Rank the "atypicality" of the newer antipsychotics based on their effects when used in patients with Parkinson's disease.